Brief: Tevogen Bio Sees $1 Bln Revenue In Launch Year For Oncology
11/08/2025 17:31
Aug 11 (Reuters) - Tevogen Bio Holdings Inc TVGN.O: FORECASTS $1 BILLION REVENUE IN LAUNCH YEAR FOR ONCOLOGY PIPELINE PROJECTING CUMULATIVE 5-YEAR ESTIMATE OF BETWEEN $10 BILLION AND $14 BILLION FOR ONCOLOGY PIPELINE Source text: ID:nGNX5TBZ1M Further company coverage: TVGN.O ((((Reuters.Briefs@thomsonreuters.com));))